Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 1 - 8 of 11607 results
Continuation Funds: Top 5 Considerations
December 20, 2024| Blog| Viewpoint
Canada’s Fall Economic Statement: A Silver Lining for Innovators Amidst the Chaos
December 18, 2024| Alert| Viewpoint
Patch, Investigate, and Defend: Critical and High Vulnerabilities in Cleo Managed File Transfer Solutions Reportedly Under Attack
December 17, 2024| Blog| Viewpoint
Preparation for 2024 Fiscal Year-End SEC Filings and 2025 Annual Shareholder Meetings
December 17, 2024| Advisory| Viewpoint
Mintz on Air: Predictions and Practical Policies – Workplace Whiplash
December 17, 2024| Podcast| Viewpoint
Key Takeaways from the OIG’s New Compliance Program Guidance for Skilled Nursing Facilities
December 16, 2024| Blog| Viewpoint
Feds’ Decision to Transfer $1.9bn Public Pension Surplus to General Revenue Within Its Purview
December 16, 2024| News
Delaware’s Consumer Privacy Law is Right Around the Corner
December 13, 2024| Blog| Viewpoint
News & Press Releases
Feds’ Decision to Transfer $1.9bn Public Pension Surplus to General Revenue Within Its Purview
December 16, 2024
Toronto Office Manager Partner Mitch Frazer was quoted by Benefits Canada in an article about the Canadian federal government’s decision to transfer $1.9 billion surplus from the Public Service Pension Plan to its general revenue.
Mintz Advises Greater Asia Pacific in Cross-Border M&A Deal
December 13, 2024
Mintz advised Greater Asia Pacific, a Hong Kong holding company, in the sale of the controlling interest in Microtek Product Services Co. Ltd. to Centre Testing International Group Co., Ltd. (CTI), a publicly traded Chinese company in the lab tasting space.
Mintz Advises Relation Therapeutics on Strategic Investment from GSK
December 13, 2024
Mintz advised Relation, an industry leader in deploying computation and experimentation to drug discovery, on an equity investment of $15 million from GSK in connection with two simultaneous strategic collaborations with GSK, a global biopharma company. The collaborations are aimed at advancing the development of novel therapeutics for fibrotic diseases and osteoarthritis – conditions which affect millions worldwide and which currently have few treatments addressing their root causes.
Events
Podcasts
The ‘Third Inning’ of the Energy Transition
December 6, 2024| Podcast|
Mintz on Air - Predictions and Practical Policies
November 25, 2024| Podcast|